Search Ontology:
ChEBI
(S)-3-{[6-(methoxymethyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}-2,3-dihydrothiophene 1,1-dioxide
- Term ID
- CHEBI:156212
- Synonyms
-
- (3S)-3-{[6-(methoxymethyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}-2,3-dihydro-1H-1lambda(6)-thiophene-1,1-dione
- (S)-3-((6-(methoxymethyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-2,3-dihydrothiophene 1,1-dioxide
- DB-8
- DB08
- DB8
- Definition
- A pyrazolopyrimidine that is pyrazolo[3,4-d]pyrimidine carrying a methoxymethyl substituent at C-6 and a [(3S)-1,1-dioxo-2,3-dihydro-1H-1lambda(6)-thiophen-3-yl]amino group at C-4. One of a series of mucosal-associated invariant T (MAIT) cell agonists.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from (S)-3-{[6-(methoxymethyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}-2,3-dihydrothiophene 1,1-dioxide
Phenotype where environments contain (S)-3-{[6-(methoxymethyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}-2,3-dihydrothiophene 1,1-dioxide
Phenotype modified by environments containing (S)-3-{[6-(methoxymethyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}-2,3-dihydrothiophene 1,1-dioxide
Human Disease Model